26.12
Rxsight Inc stock is traded at $26.12, with a volume of 736.35K.
It is up +3.57% in the last 24 hours and down -7.90% over the past month.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.
See More
Previous Close:
$25.22
Open:
$24.88
24h Volume:
736.35K
Relative Volume:
1.25
Market Cap:
$1.02B
Revenue:
$128.29M
Net Income/Loss:
$-30.69M
P/E Ratio:
-31.85
EPS:
-0.82
Net Cash Flow:
$-27.17M
1W Performance:
+7.18%
1M Performance:
-7.90%
6M Performance:
-45.08%
1Y Performance:
-48.20%
Rxsight Inc Stock (RXST) Company Profile
Name
Rxsight Inc
Sector
Industry
Phone
949-521-7822
Address
100 COLUMBIA STREET, ALISO VIEJO
Compare RXST with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
RXST
Rxsight Inc
|
26.12 | 1.02B | 128.29M | -30.69M | -27.17M | -0.82 |
![]()
ABT
Abbott Laboratories
|
131.93 | 228.81B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
100.05 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
SYK
Stryker Corp
|
377.46 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
88.86 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
72.05 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-20-24 | Downgrade | Stifel | Buy → Hold |
Dec-11-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Dec-06-24 | Initiated | UBS | Buy |
Oct-29-24 | Initiated | Jefferies | Buy |
Aug-20-24 | Reiterated | Needham | Buy |
Aug-06-24 | Reiterated | Needham | Buy |
May-07-24 | Reiterated | BTIG Research | Buy |
Dec-13-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Dec-12-23 | Initiated | Stifel | Buy |
Dec-04-23 | Initiated | Morgan Stanley | Overweight |
Apr-13-23 | Initiated | Oppenheimer | Outperform |
Dec-12-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Apr-08-22 | Initiated | Needham | Buy |
View All
Rxsight Inc Stock (RXST) Latest News
(RXST) Trading Report - news.stocktradersdaily.com
RxSight, Inc. (NASDAQ:RXST) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
BofA sees Bausch + Lomb IOL recall news as positive for RxSight - MSN
Midday Stock Roundup: Boot Barn, Beta Bionics down - Orange County Business Journal
RxSight, Inc. (NASDAQ:RXST) Shares Bought by Swiss National Bank - Defense World
RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference - GlobeNewswire
Jefferies starts coverage on Rxsight with 'buy' on growth potential - TradingView
RxSight, Inc. (NASDAQ:RXST) Shares Bought by Charles Schwab Investment Management Inc. - Defense World
Bank of America Issues Pessimistic Forecast for RxSight (NASDAQ:RXST) Stock Price - Defense World
Where are the Opportunities in (RXST) - news.stocktradersdaily.com
BofA cuts RxSight stock price target to $36, maintains Buy rating - Investing.com Canada
RxSight price target lowered to $36 from $60 at BofA - TipRanks
BofA cuts RxSight stock price target to $36, maintains Buy rating By Investing.com - Investing.com South Africa
RxSight Inc. (RXST) PT Lowered to $36 at BofA Securities - StreetInsider.com
Stifel Nicolaus Lowers RxSight (NASDAQ:RXST) Price Target to $28.00 - Defense World
RxSight (NASDAQ:RXST) Hits New 52-Week Low on Analyst Downgrade - Defense World
RxSight stock plunges to 52-week low at $24.48 amid market shifts - Investing.com Australia
RxSight stock plunges to 52-week low at $24.48 amid market shifts By Investing.com - Investing.com South Africa
Bank of New York Mellon Corp Increases Position in RxSight, Inc. (NASDAQ:RXST) - Defense World
Stifel cuts RxSight stock price target to $28 from $33 By Investing.com - Investing.com Canada
Stifel cuts RxSight stock price target to $28 from $33 - Investing.com
The Analyst Verdict: RxSight In The Eyes Of 9 Experts - Benzinga
RxSight Inc. (RXST) PT Lowered to $28 at Stifel - StreetInsider.com
RxSight price target lowered to $28 from $33 at Stifel - TipRanks
RxSight director Tamara Fountain sells $180,001 in company stock - Investing.com India
Victory Capital Management Inc. Raises Holdings in RxSight, Inc. (NASDAQ:RXST) - Defense World
Investment Analysts’ Recent Ratings Updates for RxSight (RXST) - Defense World
RxSight director Tamara Fountain sells $180,001 in company stock By Investing.com - Investing.com Australia
RxSight, Inc. (NASDAQ:RXST) Shares Slammed 27% But Getting In Cheap Might Be Difficult Regardless - Simply Wall St
RxSight, Inc. (NASDAQ:RXST) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
Principal Financial Group Inc. Purchases 3,879 Shares of RxSight, Inc. (NASDAQ:RXST) - Defense World
Rhumbline Advisers Boosts Stake in RxSight, Inc. (NASDAQ:RXST) - Defense World
RxSight stock plunges to 52-week low at $26.29 amid market challenges - Investing.com Australia
Glaukos, Tarsus, RxSight: Q4 Earnings Snapshot - Orange County Business Journal
How To Trade (RXST) - news.stocktradersdaily.com
RxSight's (RXST) Buy Rating Reaffirmed at Needham & Company LLC - MarketBeat
Wells Fargo & Company Cuts RxSight (NASDAQ:RXST) Price Target to $35.00 - Defense World
Global Retirement Partners LLC Acquires Shares of 2,000 RxSight, Inc. (NASDAQ:RXST) - Defense World
Stifel Nicolaus Cuts RxSight (NASDAQ:RXST) Price Target to $33.00 - Defense World
JPMorgan Chase & Co. Cuts RxSight (NASDAQ:RXST) Price Target to $40.00 - Defense World
RxSight’s (RXST) “Buy” Rating Reiterated at Needham & Company LLC - Defense World
RxSight (NASDAQ:RXST) Issues Quarterly Earnings Results - MarketBeat
RxSight (NASDAQ:RXST) Price Target Lowered to $35.00 at Wells Fargo & Company - MarketBeat
New York State Common Retirement Fund Boosts Holdings in RxSight, Inc. (NASDAQ:RXST) - MarketBeat
Stifel Nicolaus Has Lowered Expectations for RxSight (NASDAQ:RXST) Stock Price - MarketBeat
RxSight, Inc. (NASDAQ:RXST) Just Reported, And Analysts Assigned A US$44.80 Price Target - Simply Wall St
RxSight (NASDAQ:RXST) Shares Gap Down on Disappointing Earnings - Defense World
Rxsight Inc Stock (RXST) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):